A new 'double mutant' variant of Covid found in India: Health Ministry

Though VOCs and a new double mutant variant have been found in India, these have not been detected in sufficient numbers, says govt

Coronavirus
Representational image (Photo: Reuters)
BS Web Team
3 min read Last Updated : Mar 24 2021 | 1:34 PM IST
Genome sequencing by INSACOG showed coronavirus variants of concern and a novel variant in India, said government on Wednesday. 

The Indian SARS-CoV-2 Consortium on Genomics (INSACOG) is a grouping of 10 national laboratories that was established by Ministry of Health and Family Welfare, Govt of India on December 25, 2020. INSACOG has since then been carrying out genomic sequencing and analysis of circulating Covid-19 viruses, and correlating epidemiological trends with genomic variants. "Genomic variants of various viruses are a natural phenomenon and are found in almost all countries," said Ministry of Health and Family Welfare in a statement. 

Since INSACOG initiated its work, 771 variants of concerns (VOCs) have been detected in a total of 10,787 positive samples shared by states/UTs. These include 736 samples positive for viruses of the UK (B.1.1.7) lineage. 34 samples were found positive for viruses of the South African (B.1.351) lineage.  1 sample was found positive for viruses of the Brazilian (P.1) lineage. The samples with these VOCs have been identified in 18 states of the country. 

Genome sequencing and analysis have been carried out on samples from arriving international travelers, contacts of those positive for VOC and community samples from most of the states at INSACOG partner laboratories, which are 10 in number.

"The analysis of samples from Maharashtra has revealed that compared to December 2020, there has been an increase in the fraction of samples with the E484Q and L452R mutations.  Such mutations confer immune escape and increased infectivity. These mutations have been found in about 15-20% of samples and do not match any previously catalogued VOCs. These have been categorized as VOCs but require the same epidemiological and public health response of “increased testing, comprehensive tracking of close contacts, prompt isolation of positive cases & contacts as well as treatment as per National Treatment Protocol” by the States/UTs," the ministry said. 

From Kerala 2032 samples (from all 14 districts) have been sequenced. The N440K variant that is associated with immune escape has been found in 123 samples from 11 districts. This variant was earlier found in 33% of samples from Andhra Pradesh, and in 53 of 104 samples from Telangana. This variant has also been reported from 16 other countries including UK, Denmark, Singapore, Japan and Australia. As of now these can be at best said to be variant under investigation.

"Though VOCs and a new double mutant variant have been found in India, these have not been detected in numbers sufficient to either establish or direct relationship or explain the rapid increase in cases in some states. Genomic sequencing and epidemiological studies are continuing to further analyze the situation," the ministry further said.

India reported 47,262 new COVID-19 cases, 23,907 recoveries and 275 deaths in the last 24 hours, as per the Union Health Ministry on Wednesday.

With this, the total cases in the country mounted to 1,17,34,058 including 3,68,457 active cases and 1,12,05,160 recoveries. The death toll has gone up to 1,60,441.

With 2,31,942 active coronavirus cases, Maharashtra continues to remain the most affected state. 22,47,495 recovered from the disease while 53,589 people died in the state.

According to the Indian Council of Medical Research (ICMR), as many as 10,25,628 samples were tested on March 23. A total of 23,64,38,861 samples had been tested up to March 23.

A total of 5,08,41,286 COVID-19 vaccine doses have been administered so far.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus Vaccine

Next Story